VOSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vosol, and what generic alternatives are available?
Vosol is a drug marketed by Hikma and Saptalis Pharms and is included in two NDAs.
The generic ingredient in VOSOL is acetic acid, glacial; hydrocortisone. There are thirty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the acetic acid, glacial; hydrocortisone profile page.
Summary for VOSOL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 375 |
Patent Applications: | 298 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VOSOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VOSOL
US Patents and Regulatory Information for VOSOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | VOSOL | acetic acid, glacial | SOLUTION/DROPS;OTIC | 012179-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Saptalis Pharms | VOSOL HC | acetic acid, glacial; hydrocortisone | SOLUTION/DROPS;OTIC | 012770-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |